Onfekafusp alfa for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jun 2020: Trial registered, NCT04443010
  2. 20 Jan 2021: Trial started, NCT04443010

The trials

NCT04443010: Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

State
Under way
Phase
Phase 1 and Phase 2
People
226 planned
Started
20 Jan 2021
Primary completion
Oct 2026
Arms
Phase 1 part: Dose Finding, Phase 2 part: Signal Seeking, Phase IIb part: Activity Evaluation_treatment arm
Results
None posted
  1. 23 Jun 2020: Trial registered
  2. 20 Jan 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as L19TNF.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.